SENP1 desensitizes hypoxic ovarian cancer cells to cisplatin by up-regulating HIF-1α

被引:51
作者
Ao, Qilin [1 ,2 ]
Su, Wenjing [3 ]
Guo, Shuang [4 ]
Cai, Lei [1 ,2 ]
Huang, Lei [5 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Inst Pathol, Wuhan 430030, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Pathol, Wuhan 430030, Peoples R China
[3] Shandong Univ, Shandong Prov Hosp, Dept Pathol, Jinan 250021, Peoples R China
[4] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Pathol, Wuhan 430030, Peoples R China
[5] Cent Hosp Wuhan, Dept Obstet & Gynecol, Wuhan 430014, Peoples R China
关键词
INDUCIBLE FACTOR 1-ALPHA; FACTOR-1-ALPHA; RESISTANCE; OVEREXPRESSION; HIF1-ALPHA; STABILITY; PROTEIN; GROWTH; TUMORS; HIF-1;
D O I
10.1038/srep16396
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
070301 [无机化学]; 070403 [天体物理学]; 070507 [自然资源与国土空间规划学]; 090105 [作物生产系统与生态工程];
摘要
Hypoxia-inducible factor 1 alpha (HIF-1 alpha) is closely related to chemoresistance of ovarian cancers. Although it is reported that HIF-1 alpha can be regulated by Sentrin/SUMO-specific protease 1 (SENP1), the effects of SENP1 on HIF-1 alpha is still controversial. In this study, we identified that SENP1 positively regulated the expression of HIF-1 alpha by deSUMOylation and weakened the sensitivity of hypoxic ovarian cancer cells to cisplatin. These results indicate that SENP1 is a positive regulator of HIF-1 alpha and plays a negative role in ovarian cancer chemotherapy.
引用
收藏
页数:8
相关论文
共 28 条
[1]
Sumoylation increases HIF-1 stability and its transcriptional activity [J].
Bae, SH ;
Jeong, JW ;
Park, JA ;
Kim, SH ;
Bae, MK ;
Choi, SJ ;
Kim, KW .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 324 (01) :394-400
[2]
Birner P, 2000, CANCER RES, V60, P4693
[3]
Signalling via the hypoxia-inducible factor-1α requires multiple posttranslational mofications [J].
Brahimi-Horn, C ;
Mazure, N ;
Pouysségur, J .
CELLULAR SIGNALLING, 2005, 17 (01) :1-9
[4]
Exploiting the hypoxic cancer cell: mechanisms and therapeutic strategies [J].
Brown, JM .
MOLECULAR MEDICINE TODAY, 2000, 6 (04) :157-162
[5]
Brown JM, 1998, CANCER RES, V58, P1408
[6]
RSUME, a small RWD-containing protein, enhances SUMO conjugation and stabilizes HIF-1α during hypoxia [J].
Carbia-Nagashima, Alberto ;
Gerez, Juan ;
Perez-Castro, Carolina ;
Paez-Pereda, Marcelo ;
Silberstein, Susana ;
Stalla, Guenter K. ;
Holsboer, Florian ;
Arzt, Eduardo .
CELL, 2007, 131 (02) :309-323
[7]
BCL-xL Is a Target Gene Regulated by Hypoxia-inducible Factor-1α [J].
Chen, Ni ;
Chen, Xueqin ;
Huang, Rui ;
Zeng, Hao ;
Gong, Jing ;
Meng, Wentong ;
Lu, Yiping ;
Zhao, Fang ;
Wang, Lin ;
Zhou, Qiao .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (15) :10004-10012
[8]
SUMO-Specific protease 1 is essential for stabilization of HIF1α during hypoxia [J].
Cheng, Jinke ;
Kang, Xunlei ;
Zhang, Sui ;
Yeh, Edward T. H. .
CELL, 2007, 131 (03) :584-595
[9]
Comerford KM, 2002, CANCER RES, V62, P3387
[10]
C-elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation [J].
Epstein, ACR ;
Gleadle, JM ;
McNeill, LA ;
Hewitson, KS ;
O'Rourke, J ;
Mole, DR ;
Mukherji, M ;
Metzen, E ;
Wilson, MI ;
Dhanda, A ;
Tian, YM ;
Masson, N ;
Hamilton, DL ;
Jaakkola, P ;
Barstead, R ;
Hodgkin, J ;
Maxwell, PH ;
Pugh, CW ;
Schofield, CJ ;
Ratcliffe, PJ .
CELL, 2001, 107 (01) :43-54